Related Experiment Video
Updated: Jan 30, 2026

Proteomic Sample Preparation from Formalin Fixed and Paraffin Embedded Tissue
Published on: September 2, 2013
Cost-Efficient and Easy to Perform PCR-Based Assay to Identify Met Exon 14 Skipping in Formalin-Fixed
Odharnaith O'Brien1,2, Mark C Wright3, Cathal O'Brien4
1Thoracic Oncology Research Group, Trinity Translational Medicine Institute, St. James's Hospital, D08 W9RT Dublin, Ireland. odharnaithobrien@gmail.com.
Abstract:
MET is a receptor tyrosine kinase (RTK) that plays important roles in carcinogenesis. Despite being frequently overexpressed in cancer, clinical responses to targeting this receptor have been limited. Recently novel splicing mutations involving the loss of exon 14 (called METex14 skipping) have emerged as potential biomarkers to predict for responsiveness to targeted therapies with Met inhibitors in non-small cell lung cancer (NSCLC). Currently, the diverse genomic alterations responsible for METex14 skipping pose a challenge for routine clinical diagnostic testing. In this report, we examine three different methodologies to detect METex14 and assess their potential utility for use as a diagnostic assay for both the identification of METex14 and intra-tumoural distribution in NSCLC.
Insights
Detecting METex14 skipping mutations in non-small cell lung cancer (NSCLC) is crucial for guiding targeted therapy. This study evaluates three methods for identifying these METex14 alterations and their distribution within tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The MET receptor tyrosine kinase (RTK) is implicated in cancer development.
- Clinical efficacy of MET-targeted therapies is often limited, necessitating predictive biomarkers.
- METex14 skipping mutations are emerging as key biomarkers for predicting response to MET inhibitors in non-small cell lung cancer (NSCLC).
Purpose of the Study:
- To evaluate three distinct methodologies for detecting METex14 skipping mutations.
- To assess the utility of these methods for routine clinical diagnostics in NSCLC.
- To determine the intra-tumoural distribution of METex14 alterations.
Main Methods:
- Comparative analysis of three different techniques for detecting METex14 splicing alterations.
- Assessment of diagnostic assay potential for identified mutations.
- Evaluation of intra-tumoural heterogeneity in NSCLC samples.
Main Results:
- The study compared the sensitivity and specificity of three methods for METex14 detection.
- Potential diagnostic utility for identifying METex14 alterations was assessed.
- Intra-tumoural distribution patterns of METex14 skipping were analyzed.
Conclusions:
- Accurate detection of METex14 skipping is vital for personalized medicine in NSCLC.
- The evaluated methodologies show promise for clinical diagnostic applications.
- Understanding intra-tumoural distribution is important for effective treatment strategies.
More Related Videos
08:30Preparation of Formalin-fixed Paraffin-embedded Tissue Cores for both RNA and DNA Extraction
Published on: August 21, 2016
07:42A Novel Microdissection Approach to Recovering Mycobacterium tuberculosis Specific Transcripts from Formalin Fixed Paraffin Embedded Lung Granulomas
Published on: June 5, 2014
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
PCR
Fixing Double-strand Breaks
Fixed Action Patterns
Lung Capacity
Growth versus Fixed Mindset